Drug intelligence / Profile preview

avocadyne

Development stage
Unknown
Modality
Small Molecules
Administration
Oral (potential/dietary Supplement), Unknown (no Approved Pharmaceutical Formulation)
01

Overview

Avocadyne is a **polyhydroxylated fatty alcohol** (C₁₇H₃₂O₃) of natural origin, primarily extracted from avocado (*Persea americana*). Structurally, it is distinguished as a 17-carbon terminally unsaturated acetogenin, featuring a triple bond at the terminal carbon and hydroxyl groups at carbons 1, 2, and 4. Avocadyne exhibits **potent bioactivity through direct inhibition of very long chain acyl-CoA dehydrogenase (VLCAD)**, a key mitochondrial enzyme in the **fatty acid oxidation (FAO) pathway**. This action disrupts energy generation in **acute myeloid leukemia (AML) cells**, leading to selective induction of apoptosis in malignant, but not normal, hematopoietic cells. Preclinical evidence also supports roles in enhancing **insulin sensitivity** and **improving glucose tolerance**, with potential application in the management of diabetes. Avocadyne has shown **antiviral properties** in preclinical studies. Its presence is documented both in avocado pulp and seeds, and it is being explored as a candidate for pharmaceutical and dietary supplement use for AML and metabolic diseases[1][2][3][4][7][8].

Other names
16-heptadecyne-1,2,4-triolheptadec-16-yne-1,2,4-triolheptadecane-16-yne-1,2,4-triol1,2,4-trihydroxyheptadec-16-yne
02

Targets

VLCAD (Very long-chain acyl-CoA dehydrogenase)

Beyond the preview

Go deeper on avocadyne.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on avocadyne.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call